North America Neurologic Paraneoplastic SyndromeTreatment Market Size by Deployment, by Applications, by Type, by End-User & by Technology 2032
North America Neurologic Paraneoplastic SyndromeTreatment Market was valued at USD 0.5 Billion in 2022 and is projected to reach USD 0.8 Billion by 2030, growing at a CAGR of 6.2% from 2024 to 2030. The North American market for Neurologic Paraneoplastic Syndrome (NPS) treatments is witnessing significant